A group at Keio University Hospital has successfully transplanted human iPS cell-derived neural stem/progenitor cells (iPSC-NS/PCs) into the first participant of a clinical study on regenerative medicine using iPSC-NS/PCs for subacute spinal cord injury (SCI).